Mucosal immune responses to fungi and the implications for inflammatory bowel disease

Current Opinion in Gastroenterology

Volumn 34, Issue 6, 2018, Pages 398-403

  Limon, Jose J ^a   Kershaw, Kathleen M ^a,b   Underhill, David M ^a  

^a F Widjaja Foundation Inflammatory Bowel and Immunobiology Research Institute   (United States)

^b CEDARS SINAI MEDICAL CENTER   (United States)

Author keywords

C type lectins; CARD9; Crohn's disease; mycobiome

Indexed keywords

ADAPTATION; ENTERITIS; FUNGAL COMMUNITY; FUNGUS; HUMAN; IMMUNE RESPONSE; IMMUNE SYSTEM; INFLAMMATORY BOWEL DISEASE; INTESTINE FLORA; INTESTINE MUCOSA; NONHUMAN; REVIEW; IMMUNOLOGY; MICROBIOLOGY; MUCOSAL IMMUNITY;

FUNGI; GASTROINTESTINAL MICROBIOME; HOST MICROBIAL INTERACTIONS; HUMANS; IMMUNITY, MUCOSAL; INFLAMMATORY BOWEL DISEASES; INTESTINAL MUCOSA;

EID: 85054712832     PISSN: 02671379     EISSN: 15317056     Source Type: Journal    
DOI: 10.1097/MOG.0000000000000483     Document Type: Review

References (33)

1. Hager CL, Ghannoum MA. The mycobiome: role in health and disease, and as a potential probiotic target in gastrointestinal disease. Dig Liver Dis 2017; 49:1171-1176.
2. Richard ML, Lamas B, Liguori G, et al. Gut fungal microbiota: the Yin and Yang of inflammatory bowel disease. Inflamm Bowel Dis 2015; 21:656-665.
3. Wheeler ML, Limon JJ, Underhill DM. Immunity to commensal fungi: detente and disease. Annu Rev Pathol 2017; 12:359-385.
4. Wheeler ML, Limon JJ, Bar AS, et al. Immunological consequences of intestinal fungal dysbiosis. Cell Host Microbe 2016; 19:865-873.
5. Jostins L, Ripke S, Weersma RK, et al. Host-microbe interactions have shaped the genetic architecture of inflammatory bowel disease. Nature 2012; 491:119-124.
6. Rivas MA, Beaudoin M, Gardet A, et al. Deep resequencing of GWAS loci identifies independent rare variants associated with inflammatory bowel disease. Nat Genet 2011; 43:1066-1073.
7. Glocker EO, Hennigs A, Nabavi M, et al. A homozygous CARD9 mutation in a family with susceptibility to fungal infections. N Engl J Med 2009; 361:1727-1735.
8. Iliev ID, Funari VA, Taylor KD, et al. Interactions between commensal fungi and the C-type lectin receptor Dectin-1 influence colitis. Science 2012; 336:1314-1317.
9. Joossens S, Reinisch W, Vermeire S, et al. The value of serologic markers in indeterminate colitis: a prospective follow-up study. Gastroenterology 2002; 122:1242-1247.
10. Neville BA, d'Enfert C, Bougnoux ME. Candida albicans commensalism in the gastrointestinal tract. FEMS Yeast Res 2015; 15: pii: fov081.
11. Skalski JH, Limon JJ, Sharma P, et al. Expansion of commensal fungus Wallemia mellicola in the gastrointestinal mycobiota enhances the severity of allergic airway disease in mice. PLOS Pathog 2018; 14:e1007260.
12. Miyoshi J, Sofia MA, Pierre JF. The evidence for fungus in Crohn's disease pathogenesis. Clin J Gastroenterol 2018; In Press.
13. Ott SJ, Kuhbacher T, Musfeldt M, et al. Fungi and inflammatory bowel diseases: alterations of composition and diversity. Scand J Gastroenterol 2008; 43:831-841.
14. Chehoud C, Albenberg LG, Judge C, et al. Fungal Signature in the gut microbiota of pediatric patients with inflammatory bowel disease. Inflamm Bowel Dis 2015; 21:1948-1956.
15. Lewis JD, Chen EZ, Baldassano RN, et al. Inflammation, antibiotics, and diet as environmental stressors of the gut microbiome in pediatric Crohn's disease. Cell Host Microbe 2015; 18:489-500.
16. Sokol H, Leducq V, Aschard H, et al. Fungal microbiota dysbiosis in IBD. Gut 2017; 66:1039-1048.
17. Hamad I, Abou Abdallah R, Ravaux I, et al. Metabarcoding analysis of eukaryotic microbiota in the gut of HIV-infected patients. PLoS One 2018; 13:e0191913.
18. Kelesidis T, Pothoulakis C. Efficacy and safety of the probiotic Saccharomyces boulardii for the prevention and therapy of gastrointestinal disorders. Therap Adv Gastroenterol 2012; 5:111-125.
19. Sivananthan K, Petersen AM. Review of Saccharomyces boulardii as a treatment option in IBD. Immunopharmacol Immunotoxicol 2018; In Press.
20. Noble SM, Gianetti BA, Witchley JN. Candida albicans cell-type switching and functional plasticity in the mammalian host. Nat Rev Microbiol 2017; 15:96-108.
21. Pande K, Chen C, Noble SM. Passage through the mammalian gut triggers a phenotypic switch that promotes Candida albicans commensalism. Nat Genet 2013; 45:1088-1091.
22. Znaidi S, van Wijlick L, Hernandez-Cervantes A, et al. Systematic gene overexpression in Candida albicans identifies a regulator of early adaptation to the mammalian gut. Cell Microbiol 2018; e12890.
23. Richardson JP, Moyes DL, Ho J, Naglik JR. Candida innate immunity at the mucosa. Semin Cell Dev Biol 2018; In Press.
24. Salazar F, Brown GD. Antifungal innate immunity: a perspective from the last 10 years. J Innate Immun 2018; In Press.
25. Underhill DM, Pearlman E. Immune interactions with pathogenic and commensal fungi: a two-way street. Immunity 2015; 43:845-858.
26. Leonardi I, Li X, Semon A, et al. CX3CR1(+) mononuclear phagocytes control immunity to intestinal fungi. Science 2018; 359:232-236.
27. Kim M, Galan C, Hill AA, et al. Critical role for the microbiota in CX3CR1(+) intestinal mononuclear phagocyte regulation of intestinal T cell responses. Immunity 2018; 49:151-163.
28. Zhang Z, Li J, Zheng W, et al. Peripheral lymphoid volume expansion and maintenance are controlled by gut microbiota via RALDH+ dendritic cells. Immunity 2016; 44:330-342.
29. Tweedle JL, Deepe GS Jr. Tumor necrosis factor alpha antagonism reveals a gut/lung axis that amplifies regulatory T cells in a pulmonary fungal infection. Infect Immun 2018; 86: pii: e00109-18.
30. Renga G, Moretti S, Oikonomou V, et al. IL-9 and mast cells are key players of Candida albicans commensalism and pathogenesis in the gut. Cell Rep 2018; 23:1767-1778.
31. Guo Y, Zhou G, He C, et al. Serum levels of lipopolysaccharide and 1,3-beta-D-glucan refer to the severity in patients with Crohn's disease. Mediators Inflamm 2015; 2015:843089.
32. Yang AM, Inamine T, Hochrath K, et al. Intestinal fungi contribute to development of alcoholic liver disease. J Clin Invest 2017; 127:2829-2841.
33. Chiaro TR, Soto R, Zac Stephens W, et al. A member of the gut mycobiota modulates host purine metabolism exacerbating colitis in mice. Sci Transl Med 2017; 9:eaaf9044.